Skip to main content
. 2014 Jul 14;20(26):8583–8591. doi: 10.3748/wjg.v20.i26.8583

Table 1.

Correlations between preoperative fibrinogen and clinicopathological parameters

Parameters n Fibrinogen (g/L, mean ± SD) P value
Age (yr)
< 60 119 3.29 ± 1.01 0.047
≥ 60 136 3.07 ± 0.73
Nationality
Han 216 3.16 ± 0.87 0.892
Uygur 30 3.24 ± 0.92
Others 9 3.12 ± 0.94
BMI (kg/m2)
< 18.5 8 3.54 ± 0.82 0.638
18.5-23.99 115 3.15 ± 0.94
24-27.99 102 3.14 ± 0.83
≥ 28 30 3.23 ± 0.79
Smoking
Never 173 3.06 ± 0.82 0.018
Light 18 3.43 ± 0.74
Heavy 64 3.39 ± 0.99
Grade (tumor differentiation)
Low 203 3.12 ± 0.86 0.080
High 52 3.36 ± 0.92
TNM
I 29 2.70 ± 0.58 0.002
II 139 3.24 ± 0.95
III 87 3.21 ± 0.78
Tumor size (cm)
< 4 51 2.81 ± 0.72 0.000
4-6 114 3.01 ± 0.73
≥ 6 90 3.57 ± 0.98
Type
Mess type 104 3.13 ± 0.87 0.390
Ulceration 148 3.21 ± 0.89
Infiltrative 3 2.58 ± 0.13
Tumor location
Left 155 3.06 ± 0.82 0.020
Right 89 3.38 ± 0.97
Transverse 11 2.99 ± 0.55
Perineural invasion
Yes 7 3.40 ± 0.59 0.488
No 248 3.16 ± 0.88
Vascular invasion
Yes 13 3.29 ± 0.94 0.619
No 242 3.16 ± 0.87
CEA (ng/mL)
< 5 161 3.08 ± 0.89 0.038
≥ 5 94 3.32 ± 0.84
AFP (ng/mL)
< 5 231 3.17 ± 0.88 0.747
≥ 5 24 3.11 ± 0.82
mGPS
0 163 3.00 ± 0.77 0.000
1 71 3.37 ± 0.94
2 21 3.80 ± 1.00
WBC count
< 5 × 109/L 61 2.68 ± 0.56 0.000
≥ 5 × 109/L 194 3.32 ± 0.90
NLR
< 5 238 3.13 ± 0.86 0.013
≥ 5 17 3.69 ± 1.02
PLR
< 150 134 2.96 ± 0.75 0.000
150-300 105 3.41 ± 0.96
> 300 15 3.40 ± 0.83

AFP: Alpha-fetoprotein; BMI: Body mass index; CEA: Carcinoembryonic antigen; mGPS: Modified Glasgow prognostic score; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; TNM: Tumor-node-metastasis; WBC: White blood cell.